1. Smoking in pregnancy and lactation: a review of risks and cessation strategies

   • Adrienne Einarson
   • Sara Riordan

   Review Article 24 January 2009 Pages: 325 - 330

2. Hepatotoxicity from green tea: a review of the literature and two unpublished cases

   • Gabriela Mazzanti
   • Francesca Menniti-Ippolito
   • Sabina Mastrangelo

   Review Article 06 February 2009 Pages: 331 - 341

3. Onset of analgesia with sodium ibuprofen, ibuprofen acid incorporating poloxamer and acetaminophen—a single-dose, double-blind, placebo-controlled study in patients with post-operative dental pain

   • Stephen Daniels
   • Sandie Reader
   • Michael Goulder

   Clinical Trial 28 February 2009 Pages: 343 - 353

   

4. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam

   • M. I. Veiga
   • S. Asimus
   • J. P. Gil

   Pharmacogenetics 01 November 2008 Pages: 355 - 363

   

5. Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis

   • Jonatan D. Lindh
   • Lennart Holm
   • Anders Rane

   Pharmacogenetics 25 November 2008 Pages: 365 - 375

   

6. CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking

   • Wiratchanee Mahavorasirikul
   • Wichittra Tassaneeyakul
   • Kesara Na-Bangchang

   Pharmacogenetics 13 December 2008 Pages: 377 - 384

   

7. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity

   • S. Nagassaki
   • R. D. Herculano
   • J. E. Tanus-Santos

   Pharmacogenetics 23 December 2008 Pages: 385 - 392

   

8. Clinical pharmacology of exogenously administered alkaline phosphatase

   • P. Pickkers
   • F. Snellen
   • J. G. van der Hoeven

   Pharmacokinetics and Disposition Open access 02 December 2008 Pages: 393 - 402

   

9. Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation

   • Lan Fan
   • Jin-Chao Wang
   • Hong-Hao Zhou

   Pharmacokinetics and Disposition 09 December 2008 Pages: 403 - 409

   

10. Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?

    • Alexander Jetter
    • Martina Kinzig
    • Uwe Fuhr

    Pharmacokinetics and Disposition 13 December 2008 Pages: 411 - 417

    

11. Clinical pharmacokinetics of aminoglycosides in the neonate: a review

    • Gian Maria Pacifici

    Pharmacokinetics and Disposition 23 December 2008 Pages: 419 - 427

12. Tramadol withdrawal in a neonate after long-term analgesic treatment of the mother

    • C. Willaschek
    • E. Wolter
    • R. Buchhorn

    Letter to the Editors 16 December 2008 Pages: 429 - 430

13. Immortal time bias in the association of n-3 fatty acid supplementation and atrial fibrillation

    • Alvaro Alonso

    Letter to the Editors 07 February 2009 Pages: 431 - 431

14. Pharmacogenomics and Personalized Medicine—does it fit into a book?

    • Julia Kirchheiner

    Book Review 25 February 2009 Pages: 433 - 434